Abiomed to Present at Upcoming Investor Conferences
May 29 2019 - 9:34AM
Business Wire
Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough
heart support technologies, today announced that Michael R.
Minogue, Chairman, President and Chief Executive Officer, will
present at two upcoming conferences:
- Jefferies Global Healthcare Conference
on Tuesday, June 4, 2019 at 4:30pm ET. The conference will be held
at Grand Hyatt, New York, NY.
- William Blair Growth Conference on
Wednesday, June 5, 2019 at 12:40pm CT. The conference will take
place at the Loews Hotel, Chicago, IL.
ABOUT ABIOMED
Based in Danvers, Massachusetts, Abiomed, Inc. is a leading
provider of medical devices that provide circulatory support. Our
products are designed to enable the heart to rest by improving
blood flow and/or performing the pumping of the heart. For
additional information, please visit: www.abiomed.com.
FORWARD-LOOKING STATEMENTS
This release contains forward-looking statements, including
statements regarding development of Abiomed's existing and new
products, the Company's progress toward commercial growth, and
future opportunities and expected regulatory approvals. The
Company's actual results may differ materially from those
anticipated in these forward-looking statements based upon a number
of factors, including uncertainties associated with development,
testing and related regulatory approvals, including the potential
for future losses, complex manufacturing, high quality
requirements, dependence on limited sources of supply, competition,
technological change, government regulation, litigation matters,
future capital needs and uncertainty of additional financing, and
other risks and challenges detailed in the Company's filings with
the Securities and Exchange Commission, including the most recently
filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
Readers are cautioned not to place undue reliance on any
forward-looking statements, which speak only as of the date of this
release. The Company undertakes no obligation to publicly release
the results of any revisions to these forward-looking statements
that may be made to reflect events or circumstances that occur
after the date of this release or to reflect the occurrence of
unanticipated events.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190529005603/en/
Ingrid Goldberg WardDirector, Investor
Relations978-646-1590igoldberg@abiomed.com
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Sep 2023 to Sep 2024